Format

Send to

Choose Destination
Eur Respir J. 2017 May 25;49(5). pii: 1700356. doi: 10.1183/13993003.00356-2017. Print 2017 May.

Long-lasting tuberculous pleurisy.

Author information

1
Dept of Epidemiology and Preclinical Research, Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
2
South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa.
3
Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
4
Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, San Raffaele Scientific Institute, HSR, Milan, Italy.
5
Leiden University Medical Center, Leiden, The Netherlands.
6
Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
7
Tuberculosis and Hepatitis Programme, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
8
Dept of Epidemiology and Preclinical Research, Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy delia.goletti@inmi.it.
PMID:
28546275
DOI:
10.1183/13993003.00356-2017
[Indexed for MEDLINE]
Free full text

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center